EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The inhibitory effect of hepatic cancer energy metabolism on immune checkpoint therapy: perspectives from single-cell multi-omics analysis

Xin Li, Ling Tang, Ju Cao, Yao Liu

Frontiers in Immunology · 13.04.2026 · 17

DOI: 10.3389/fimmu.2026.1753670 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Immunology, online erschienen am 13.04.2026. Verfasst von Xin Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, First Affiliated Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Immune Checkpoint Inhibitors, Carcinoma, Hepatocellular, Energy Metabolism. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate metabolic reprogramming—especially pyruvate metabolism—in hepatocellular carcinoma (HCC) before and after immune checkpoint inhibitor (ICI) therapy, construct a metabolism-related prognostic model, and evaluate the therapeutic potential of targeting LDHA.

Methods

Integrated single-cell RNA-seq data (GEO, Mendeley) were analyzed using Seurat, AUCell, pySCENIC, CellChat, and Monocle. A prognostic model was developed from TCGA data by Cox and Lasso regression. Functional validation included in vitro CCK8 and Transwell assays in Huh7 cells and in vivo xenograft experiments combining the LDHA inhibitor (R)-GNE-140 with a PD-1 antibody.

Results

Post-ICI, HCC cells upregulated pyruvate metabolism genes (LDHA, LDHB, LDHD) but showed decreased glycolysis, lactate buildup, reduced acetylation, and suppressed TCA cycle with AMPK activation. Key transcription factors (MYC, SP5, HLF, SREBF1) were identified. CellChat revealed enhanced SPP1–CD44 and APOA1–ABCA1 signaling. Pseudotime analysis indicated terminal hepatocyte differentiation. The pyruvate metabolism-based signature predicted prognosis effectively. Combination therapy with (R)-GNE-140 and PD-1 blockade inhibited Huh7 proliferation, migration, and xenograft tumor growth without liver or renal toxicity.

Conclusion

ICI therapy induces metabolic remodeling in HCC, marked by pyruvate metabolism dysregulation and lactate accumulation, contributing to resistance. Dual targeting of LDHA and PD-1 enhances antitumor efficacy, and the identified metabolic signature may serve as a prognostic biomarker and therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsImmune Checkpoint InhibitorsCarcinoma, HepatocellularEnergy MetabolismHumansAnimalsMetabolic ReprogrammingMiceMultiomicsSingle-Cell AnalysisCell Line, TumorXenograft Model Antitumor AssaysGene Expression Regulation, NeoplasticPrognosisL-Lactate DehydrogenasePyruvic Acid

Stichwörter der Autor:innen

drug resistanceenergy metabolismhepatocellular carcinomaimmune checkpoint inhibitorsprognosispyruvate metabolismsingle-cell sequencing

Substanzen

Immune Checkpoint InhibitorsL-Lactate DehydrogenasePyruvic Acid

Autor:innen und Institutionen

  • Department of Laboratory Medicine, First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Zitieren

APA

Li, X., Tang, L., Cao, J., & Liu, Y. (2026). The inhibitory effect of hepatic cancer energy metabolism on immune checkpoint therapy: perspectives from single-cell multi-omics analysis. Frontiers in Immunology, 17. https://doi.org/10.3389/fimmu.2026.1753670

Vancouver

Li X, Tang L, Cao J, Liu Y. The inhibitory effect of hepatic cancer energy metabolism on immune checkpoint therapy: perspectives from single-cell multi-omics analysis. Frontiers in Immunology. 2026;17. doi:10.3389/fimmu.2026.1753670

BibTeX
@article{Li2026,
  author = {Li, Xin and Tang, Ling and Cao, Ju and Liu, Yao},
  title = {The inhibitory effect of hepatic cancer energy metabolism on immune checkpoint therapy: perspectives from single-cell multi-omics analysis},
  journal = {Frontiers in Immunology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fimmu.2026.1753670}
}
Kostenlos starten →